Department of Pathology Microbiology and Immunology

Jennifer Gaddy, PhD
February 24, 2026

Jennifer Gaddy elected to American Academy of Microbiology 

Gaddy is a leading researcher in bacterial pathogenesis, innate immunity and reproductive immunology.

C. difficile bacteria (image courtesy of CDC/Jennifer Oosthuizen)
February 18, 2026

Vanderbilt research offers new hope for preventing repeated C. diff infections

Treatment options are limited for the more than 500,000 people in the U.S. who are diagnosed annually with C. diff infections, but researchers are working on potential vaccines, therapeutic antibodies and — most recently — nanobodies, to prevent and treat C. diff infections.

February 18, 2026

Novel vaccine protects against C. diff disease and recurrence

New study represents a major step forward for vaccine development for C. diff, the leading cause of health care- and antibiotic-associated infection.

(iStock)
February 13, 2026

Anti-Marburg antibody from Vanderbilt Health sent to Ethiopia during outbreak

There currently are no approved treatments or vaccines to protect against the infection, which can cause internal bleeding, organ failure, and in roughly 50% of cases, death.

George C. Hill, PhD. (photo by Anne Rayner)
February 5, 2026

Vanderbilt Health mourns loss of pioneering scientist George C. Hill, professor emeritus

Dr. Hill transformed medical education at Vanderbilt and conducted groundbreaking research on African sleeping sickness.

(Adobe Stock)
January 16, 2026

Vanderbilt Health team finds potent antibody that neutralizes two dangerous viruses

The single administration of an antibody that provides cross-protection against both RSV and hMPV infection could provide logistical and economic advantages over the need to develop and administer multiple virus-specific monoclonal antibodies.